VALENCIA, Calif. September 13, 2022 and MELBOURNE, Australia, September 14, 2022 — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin ...